These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10588233)

  • 1. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction.
    Ueda Y; Kitakaze M; Komamura K; Minamino T; Asanuma H; Sato H; Kuzuya T; Takeda H; Hori M
    J Am Coll Cardiol; 1999 Dec; 34(7):2120-5. PubMed ID: 10588233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase.
    Kitakaze M; Node K; Minamino T; Komamura K; Funaya H; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
    Circulation; 1996 Feb; 93(4):781-91. PubMed ID: 8641008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart.
    Komamura K; Kitakaze M; Funaya H; Ueda Y; Node K; Minamino T; Kurihara T; Hori M
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):775-83. PubMed ID: 9436817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
    Sanada S; Asanuma H; Minamino T; Node K; Takashima S; Okuda H; Shinozaki Y; Ogai A; Fujita M; Hirata A; Kim J; Asano Y; Mori H; Tomoike H; Kitamura S; Hori M; Kitakaze M
    Circulation; 2004 Oct; 110(15):2143-9. PubMed ID: 15451788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity.
    Minamino T; Kitakaze M; Morioka T; Node K; Komamura K; Takeda H; Inoue M; Hori M; Kamada T
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H238-44. PubMed ID: 8769757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts.
    Kitakaze M; Node K; Asanuma H; Takashima S; Sakata Y; Asakura M; Sanada S; Shinozaki Y; Mori H; Kuzuya T; Hori M
    Circ Res; 2000 Aug; 87(4):303-8. PubMed ID: 10948064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic preconditioning and infarct mass: the effect of hypercholesterolemia and endothelial dysfunction.
    Jung O; Jung W; Malinski T; Wiemer G; Schoelkens BA; Linz W
    Clin Exp Hypertens; 2000 Feb; 22(2):165-79. PubMed ID: 10744357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels.
    Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
    Am J Physiol; 1996 May; 270(5 Pt 2):H1744-56. PubMed ID: 8928882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    J Clin Invest; 1994 May; 93(5):2197-205. PubMed ID: 8182151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
    Miki T; Miura T; Bünger R; Suzuki K; Sakamoto J; Shimamoto K
    Am J Physiol; 1998 Oct; 275(4):H1329-37. PubMed ID: 9746483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Adenosine Formation by Ecto-5'-Nucleotidase (CD73) Is No Essential Trigger for Early Phase Ischemic Preconditioning.
    Wolff G; Truse R; Decking U
    PLoS One; 2015; 10(8):e0135086. PubMed ID: 26261991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart.
    Node K; Kitakaze M; Minamino T; Tada M; Inoue M; Hori M; Kamada T
    Br J Pharmacol; 1997 Jan; 120(2):273-81. PubMed ID: 9117120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits.
    Tang XL; Stein AB; Shirk G; Bolli R
    Basic Res Cardiol; 2004 Nov; 99(6):395-403. PubMed ID: 15372283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits.
    Bao N; Minatoguchi S; Kobayashi H; Yasuda S; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Arai M; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H
    Circ J; 2007 Oct; 71(10):1622-8. PubMed ID: 17895562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart.
    Tsukamoto O; Asanuma H; Kim J; Minamino T; Takashima S; Ogai A; Hirata A; Fujita M; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1460-6. PubMed ID: 16271703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute brain death abolishes the cardioprotective effects of ischemic preconditioning in the rabbit.
    Kirsch M; Farhat F; Garnier JP; Loisance D
    Transplantation; 2000 May; 69(10):2013-9. PubMed ID: 10852589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine and cardioprotection in the diseased heart.
    Kitakaze M; Minamino T; Node K; Takashima S; Funaya H; Kuzuya T; Hori M
    Jpn Circ J; 1999 Apr; 63(4):231-43. PubMed ID: 10475769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Takayama M; Matsubara M; Arakawa E; Takada C; Ina Y; Hasegawa K; Yao K
    Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.